Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2
/in Dendritic Cells, Hypernephroma, International Publications /von 2010-05-01 / J. Immunother. 2010 May;33(4):425-34Current status of immunological therapies for prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-05-01 / Curr Opin Urol 2010 May;20(3):241-6Cutting edge: delay and reversal of T cell tolerance by intratumoral injection of antigen-loaded dendritic cells in an autochthonous tumor model
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-04-28 / J. Immunol. 2010 Jun;184(11):5954-8Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors
/in Dendritic Cells, International Publications /von 2010-04-20 / Semin. Immunol. 2010 Jun;22(3):173-82Antigen-specific polyclonal cytotoxic T lymphocytes induced by fusions of dendritic cells and tumor cells
/in Dendritic Cells, International Publications /von 2010-04-07 / J. Biomed. Biotechnol. 2010;2010:752381Dendritic cell vaccines to combat glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2010-04-01 / Expert Rev Neurother 2010 Apr;10(4):483-6Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours
/in Brain Tumors in Children, Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2010-04-01 / Pediatr Blood Cancer 2010 Apr;54(4):519-25Differential effects of Paclitaxel on dendritic cell function
/in Dendritic Cells, International Publications /von 2010-03-19 / BMC Immunol. 2010 Mar;11:14Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells
/in Dendritic Cells, International Publications /von 2010-03-18 / Ann. Hematol. 2010 Aug;89(8):795-801
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de